Jakarta, Oct. 24 -- Indonesia's state-owned vaccine manufacturer Bio Farma is strengthening global vaccine development through its role in the Developing Countries Vaccine Manufacturers Network (DCVMN), underscoring the nation's growing influence in global health collaboration.

Bio Farma President Director Shadiq Akasya stated that the company's active involvement in DCVMN reflects Indonesia's transformation from a recipient of global health technology to a contributor shaping international vaccine standards and innovation.

"The active participation of Bio Farma's experts in DCVMN's working groups demonstrates Indonesia's commitment to driving innovation and setting new global benchmarks in vaccine development," Shadiq said in a stateme...